Effectiveness of qigong and tai chi in the quality of life of patients with cancer: protocol for an umbrella review.
complementary medicine
oncology
sports medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
entrez:
2
4
2022
pubmed:
3
4
2022
medline:
6
4
2022
Statut:
epublish
Résumé
Qigong and tai chi (QTC) have been adopted by many patients with cancer as a complementary treatment with their conventional mainstream cancer management. Findings from current systematic reviews are inconsistent. Some research indicated that either qigong or tai chi interventions could enhance quality of life (QoL), and improve cancer-related symptoms such as fatigue, sleep disturbance and anxiety; while others argued that there was a lack of efficacy of QTC on QoL improvement. This umbrella review will analyse and synthesise the findings from published systematic reviews and meta-analyses regarding the effectiveness of QTC in the QoL of patients with cancer. Twenty-five databases will be searched from their respective inception to December 2021. We will conduct a search in 21 English and 4 Chinese databases to identify qualified systematic reviews and meta-analyses. Two reviewers will independently screen all the titles and abstracts, and determine whether the article meets the inclusion criteria. After the identified systematic reviews and/or meta-analyses are confirmed, important information from each article will be extracted to the characteristics table by two reviewers independently. Two reviewers will independently analyse the quality of the selected reviews based on the Assessment of Multiple Systematic Reviews guideline. Findings from the systematic reviews and/or meta-analyses will be summarised and reported. This review does not require ethics approval as the study is based on the published articles. The results drawn from the present review will be submitted to peer-reviewed journals for publication or presented at conferences. CRD42021253216.
Identifiants
pubmed: 35365537
pii: bmjopen-2021-057980
doi: 10.1136/bmjopen-2021-057980
pmc: PMC8977801
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e057980Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Support Care Cancer. 2007 May;15(5):497-503
pubmed: 17103197
J Clin Oncol. 2017 Jun 10;35(17):1913-1920
pubmed: 28426375
Asian Pac J Cancer Prev. 2014;15(8):3715-20
pubmed: 24870782
Gynecol Oncol. 2014 Dec;135(3):510-7
pubmed: 25281491
Evid Based Complement Alternat Med. 2019 Oct 21;2019:3705120
pubmed: 31772593
Complement Ther Med. 2014 Feb;22(1):173-86
pubmed: 24559833
Evid Based Complement Alternat Med. 2020 Sep 04;2020:7607161
pubmed: 32952591
Int J Nurs Stud. 2013 May;50(5):688-707
pubmed: 22921317
Integr Cancer Ther. 2012 Jun;11(2):101-10
pubmed: 21715370
Qual Life Res. 2017 Sep;26(9):2321-2331
pubmed: 28421384
BMC Med Res Methodol. 2007 Feb 15;7:10
pubmed: 17302989
Int J Environ Res Public Health. 2020 Jul 12;17(14):
pubmed: 32664702
Ann Oncol. 2010 Mar;21(3):608-614
pubmed: 19880433
Am J Health Promot. 2010 Jul-Aug;24(6):e1-e25
pubmed: 20594090